Easy booking, trusted specialists, and compassionate multispeciality care.
Minimally Invasive Treatment for Congenital Heart Defects
Device closure procedures for Atrial Septal Defect (ASD), Ventricular Septal Defect (VSD), and Patent Ductus Arteriosus (PDA) offer a safe and effective minimally invasive alternative to open-heart surgery. At Serenity Health Care, we provide advanced transcatheter device closure interventions to correct these congenital heart defects, restore normal blood circulation, and protect long-term heart function.
Congenital heart defects can place excessive strain on the heart and lungs if left untreated. Early diagnosis and timely correction are essential to prevent complications such as heart failure, pulmonary hypertension, and reduced quality of life.
Atrial Septal Defect (ASD) is an opening between the upper chambers of the heart that allows abnormal blood flow between the atria.
Ventricular Septal Defect (VSD) is a hole between the lower chambers, causing oxygen-rich and oxygen-poor blood to mix.
Patent Ductus Arteriosus (PDA) is a persistent connection between two major blood vessels near the heart that normally closes after birth.
These defects can vary in size and severity. Small defects may remain asymptomatic, while larger defects can lead to breathlessness, fatigue, recurrent infections, poor growth, or heart enlargement over time.
Device closure is recommended for patients with significant ASD, VSD, or PDA that causes symptoms, heart enlargement, abnormal blood flow, or increased pressure in the lungs. It is suitable for children and adults who meet anatomical and clinical criteria for catheter-based closure.
Patients with evidence of worsening heart function, reduced exercise tolerance, or recurrent respiratory symptoms may benefit from early intervention. Careful evaluation ensures that device closure is both safe and effective for each individual.
Transcatheter device closure offers several advantages over open surgical repair. These include avoidance of large surgical incisions, reduced pain, shorter hospital stay, faster recovery, and minimal disruption to daily life.
By correcting abnormal blood flow, device closure helps normalize heart workload, improve symptoms, prevent long-term complications, and support normal growth and development in younger patients. Many patients experience significant improvement in energy levels and exercise capacity after successful closure.
At Serenity Health Care, device closure procedures begin with a detailed clinical and imaging evaluation to assess defect size, location, and suitability for catheter-based treatment. Advanced imaging techniques are used to plan the procedure with precision.
During the procedure, a catheter is guided through a blood vessel to the heart, and a specially designed closure device is deployed to seal the defect. The device expands securely on both sides of the opening, effectively stopping abnormal blood flow.
The procedure is performed under careful monitoring to ensure accuracy and safety. After closure, patients are observed and provided with structured post-procedure care and follow-up guidance. Most patients recover quickly and can resume normal activities as advised.
Device closures are designed to remain permanently in place and become integrated with heart tissue over time. Regular follow-up ensures proper device position, heart function, and long-term success.
Patients receive guidance on activity, medications when required, and routine follow-up schedules to maintain optimal heart health.
Expertise in transcatheter congenital heart defect interventions
Minimally invasive treatment with faster recovery
Evidence-based patient selection and procedural planning
Focus on safety, precision, and long-term outcomes
Seamless coordination with comprehensive cardiology services
Serenity Health Care offers advanced and compassionate care for patients requiring device closure of ASD, VSD, or PDA in a modern, patient-centered environment. Our team is committed to restoring normal heart function, preventing complications, and supporting lifelong cardiac health.
Correcting congenital heart defects early can transform lives — and expert, minimally invasive care makes that possible.
